Insiders · KZIA

Ebru Davidson

Director at Kazia Therapeutics Ltd (KZIA) since March 2026

Ebru Davidson has filed 2 insider reports with the SEC since June 2026, as director at Kazia Therapeutics Ltd (KZIA). The latest filing, on July 8, 2026, reports grant or award at Kazia Therapeutics Ltd (KZIA).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Ebru Davidson is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Kazia Therapeutics Ltd logo
KZIA
Kazia Therapeutics Ltd
Directorsince March 2026$4.92Jul 8, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Ebru Davidson with

Other insiders at the same companies

Questions about Ebru Davidson

What is Ebru Davidson's role at Kazia Therapeutics Ltd?
Ebru Davidson reports to the SEC as director at Kazia Therapeutics Ltd (KZIA), according to the latest filing on July 8, 2026.
Has Ebru Davidson bought or sold stock recently?
No open-market purchases or sales by Ebru Davidson are on file. The filings report grant or award.
How do I get alerts when Ebru Davidson files?
Follow Ebru Davidson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Ebru Davidson (SEC CIK 0002135805). Totals count each trade once, skipping amendments whose original is on file, from Jun 4, 2026 on. View on SEC EDGAR · Get this as JSON